Literature DB >> 24343771

Assay formats: Recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team.

Sherri Dudal1, Daniel Baltrukonis, Rebecca Crisino, M Jaya Goyal, Alison Joyce, Karolina Osterlund, John Smeraglia, Yoshitaka Taniguchi, Jihong Yang.   

Abstract

As part of the GBC (Global Bioanalysis Consortium), the L3 assay format team has focused on reviewing common platforms used to support ligand binding assays in the detection of biotherapeutics. The following review is an overview of discussions and presentations from around the globe with a group of experts from different companies to allow an international harmonization of common practices and suggestions for different platforms. Some of the major platforms include Gyrolab, Erenna, RIA, AlphaLISA, Delfia, Immuno-PCR, Luminex, BIAcore, and ELISAs. The review is meant to support bioanalysts in taking decisions between different platforms depending on the needs of the analyte with a number of recommendations to help integration of platforms into a GLP environment.

Mesh:

Substances:

Year:  2013        PMID: 24343771      PMCID: PMC3933581          DOI: 10.1208/s12248-013-9552-9

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  22 in total

Review 1.  Electrogenerated chemiluminescence.

Authors:  Robert J Forster; Paolo Bertoncello; Tia E Keyes
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2009       Impact factor: 10.745

2.  Pharmacokinetics of natural mistletoe lectins after subcutaneous injection.

Authors:  Roman Huber; Jürgen Eisenbraun; Barbara Miletzki; Michael Adler; Rainer Scheer; Reinhild Klein; Christoph H Gleiter
Journal:  Eur J Clin Pharmacol       Date:  2010-05-14       Impact factor: 2.953

Review 3.  Bioanalytical method validation for macromolecules in support of pharmacokinetic studies.

Authors:  JoMarie Smolec; Binodh DeSilva; Wendell Smith; Russell Weiner; Marian Kelly; Ben Lee; Masood Khan; Richard Tacey; Howard Hill; Abbie Celniker; Vinod Shah; Ronald Bowsher; Anthony Mire-Sluis; John W A Findlay; Mary Saltarelli; Valerie Quarmby; David Lansky; Robert Dillard; Martin Ullmann; Stephen Keller; H Thomas Karnes
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

4.  Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.

Authors:  C T Viswanathan; Surendra Bansal; Brian Booth; Anthony J DeStefano; Mark J Rose; Jeffrey Sailstad; Vinod P Shah; Jerome P Skelly; Patrick G Swann; Russell Weiner
Journal:  Pharm Res       Date:  2007-04-26       Impact factor: 4.200

Review 5.  Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendations.

Authors:  Douglas M Fast; Marian Kelley; C T Viswanathan; Jacqueline O'Shaughnessy; S Peter King; Ajai Chaudhary; Russell Weiner; Anthony J DeStefano; Daniel Tang
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

6.  Bioanalytical platform comparison using a generic human IgG PK assay format.

Authors:  Beth A Leary; Rosemary Lawrence-Henderson; Carolyn Mallozzi; Mireia Fernandez Ocaña; Nicole Duriga; Denise M O'Hara; Mania Kavosi; Qiang Qu; Alison P Joyce
Journal:  J Immunol Methods       Date:  2013-08-29       Impact factor: 2.303

7.  Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.

Authors:  Katie St Ledger; Sara J Agee; Marion T Kasaian; Stephen B Forlow; Billie L Durn; Jennifer Minyard; Quynh Anh Lu; John Todd; Ole Vesterqvist; Michael E Burczynski
Journal:  J Immunol Methods       Date:  2009-09-02       Impact factor: 2.303

8.  Comparison of chemiluminescent assays and colorimetric ELISAs for quantification of murine IL-12, human IL-4 and murine IL-4: chemiluminescent substrates provide markedly enhanced sensitivity.

Authors:  I P Lewkowich; J D Campbell; K T HayGlass
Journal:  J Immunol Methods       Date:  2001-01-01       Impact factor: 2.303

9.  Ultrasensitive flow-based immunoassays using single-molecule counting.

Authors:  John Todd; Bob Freese; Ann Lu; Douglas Held; Jennifer Morey; Richard Livingston; Philippe Goix
Journal:  Clin Chem       Date:  2007-09-21       Impact factor: 8.327

10.  Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab.

Authors:  James A Lofgren; Sripriya Dhandapani; Jason J Pennucci; Christina M Abbott; Daniel T Mytych; Arunan Kaliyaperumal; Steven J Swanson; Michael C Mullenix
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

View more
  9 in total

1.  Data quality in drug discovery: the role of analytical performance in ligand binding assays.

Authors:  Hermann Wätzig; Imke Oltmann-Norden; Franziska Steinicke; Hassan A Alhazmi; Markus Nachbar; Deia Abd El-Hady; Hassan M Albishri; Knut Baumann; Thomas Exner; Frank M Böckler; Sami El Deeb
Journal:  J Comput Aided Mol Des       Date:  2015-06-13       Impact factor: 3.686

Review 2.  Emerging technologies to increase ligand binding assay sensitivity.

Authors:  Saloumeh K Fischer; Alison Joyce; Mark Spengler; Tong-Yuan Yang; Yao Zhuang; Marianne Scheel Fjording; Alvydas Mikulskis
Journal:  AAPS J       Date:  2014-10-18       Impact factor: 4.009

3.  Singlicate Ligand Binding Assay Using an Automated Microfluidic System: a Clinical Case Study.

Authors:  Hao Jiang; Alex Kozhich; Jennifer Cummings; Janice Gambardella; Frank Zambito; Craig Titsch; Jonathan Haulenbeek; Kelli Phillips; Ross Fergus; Heather Myler
Journal:  AAPS J       Date:  2017-06-06       Impact factor: 4.009

4.  Introduction to the proposals from the global bioanalysis consortium harmonization team.

Authors:  Philip Timmerman; Mark Arnold; Binodh DeSilva; Fabio Garofolo; Michaela Golob; Peter van Amsterdam; Shinobu Kudoh; Puran Singhal; Daniel Tang; Maria Francesca Riccio; Rafael Barrientos; Shrinivas Savale; Tatsuo Kurokawa
Journal:  AAPS J       Date:  2014-10-02       Impact factor: 4.009

5.  Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab Platform.

Authors:  Tracey H Clark; Phillip D Yates; Allison Given Chunyk; Alison P Joyce; Aidong Wu; Petar Pop-Damkov; Yiqun Zhang; Elizabeth A Dreher; Laurie A Tylaska; Jo-Ann A Wentland; Kathleen B Pelletier; Lindsay E King; Chad A Ray
Journal:  AAPS J       Date:  2016-07-11       Impact factor: 4.009

6.  Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study.

Authors:  Megan Eb Clowse; Frauke Förger; Caroline Hwang; John Thorp; Radboud Jem Dolhain; Astrid van Tubergen; Laura Shaughnessy; Jeff Simpson; Marie Teil; Nathalie Toublanc; Maggie Wang; Thomas W Hale
Journal:  Ann Rheum Dis       Date:  2017-08-16       Impact factor: 19.103

7.  Fully integrated rapid microfluidic device translated from conventional 96-well ELISA kit.

Authors:  M Jalal Uddin; Nabil H Bhuiyan; Joon S Shim
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

8.  Longitudinal assessment of salivary vitamin D binding protein during orthodontic tooth movement.

Authors:  Nada Tashkandi; Yihong Zhao; Gabrielle Mitchell-Lee; Danielle Stephens; Michele Patel; Melih Motro; Leslie A Will; Alpdogan Kantarci
Journal:  BMC Oral Health       Date:  2021-07-05       Impact factor: 2.757

9.  Evaluating polymicrobial immune responses in patients suffering from tick-borne diseases.

Authors:  Kunal Garg; Leena Meriläinen; Ole Franz; Heidi Pirttinen; Marco Quevedo-Diaz; Stephen Croucher; Leona Gilbert
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.